| Title: | Alpha-1 antitrypsin deficiency and primary liver cancers |
| Journal: | Biochimica et Biophysica Acta (BBA) - Reviews on Cancer |
| Published: | 23 Feb 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39999944/ |
| DOI: | https://doi.org/10.1016/j.bbcan.2025.189290 |
Publication 15890
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Primary liver cancers (PLCs) remain a major challenge to global health and an escalating threat to human life, with a growing incidence worldwide. PLCs are composed of hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA), and mixed HCC-CCA, accounting for 85 %, 10 %, and 5 % of cases, respectively. Among the numerous identified risk factors associated with liver cancers, Alpha 1-AntiTrypsin Deficiency (AATD) genetic disease emerges as an intriguing one. AATD-related liver disease may lead to chronic hepatitis, cirrhosis, and PLCs in adulthood. Although our knowledge about the natural history of AATD-liver disease has improved recently, liver cancers associated with AATD remain poorly understood and explored, while this specific population is at a 20 to 50 times higher risk of developing PLC. Thus, we review here current knowledge about AATD-associated PLCs, describing the impact of AATD genotypes on their occurrence. We also discuss emerging hypotheses regarding the AATD PiZZ genotype-related hepatic carcinogenesis process. Finally, we perform an updated analysis of the United Kingdom Biobank database that highlights and confirms AATD PiZZ genotype as an important HCC risk factor.</p>
11 Authors
- Carolin Victoria Schneider
- Marie Decraecker
- Aurélie Beaufrère
- Audrey Payancé
- Audrey Coilly
- Kai Markus Schneider
- Paulette Bioulac
- Jean-Frédéric Blanc
- Brigitte Le Bail
- Samuel Amintas
- Marion Bouchecareilh
1 Application
| Application ID | Title |
|---|---|
| 71300 | Elucidating host-environment interactions in gastrointestinal diseases |
Enabling scientific discoveries that improve human health